Skip to main content
. 2021 May 27;11:664304. doi: 10.3389/fonc.2021.664304

Table 1.

Patient characteristics of all included patients.

Training Cohort (n=28) Validation Cohort (n=12)
Tumor location
 Oropharynx 19 (68%) 6 (50%)
 Hypopharynx 5 (18%) 4 (33%)
 Larynx 3 (11%) 0 (0%)
 Oral Cavity 1 (3%) 2 (17%)
Time to recurrence (median [range] months) 7 [2 - 59] 8 [4 -24]
T stage
 1 1 (3%) 0 (0%)
 2 5 (18%) 0 (0%)
 3 7 (25%) 3 (25%)
 4 15 (54%) 9 (75%)
N stage
 0 5 (18%) 2 (17%)
 1 4 (14%) 1 (8%)
 2a 0 (0%) 1 (8%)
 2b 7 (25%) 2 (17%)
 2c 12 (43%) 6 (50%)
 3 0 (0%) 0 (0%)
HPV status
 Positive 3 (11%) 3 (25%)
 Negative 12 (43%) 8 (67%)
 Unknown 13 (46%) 1 (8%)